SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Company filed a Certificate of Designation on June 24, 2026, creating 150,000 shares of Series B Convertible Preferred Stock with a conversion price of $1.25 per share, following stockholder approval on June 23, 2026. The Series B Preferred Stock is convertible into Common Stock and represents a dilutive issuance to Omnia pursuant to the Omnia Venture Agreements.
View raw filing on EDGAR →Cybin Inc. announced an underwritten public offering of 10,309,280 common shares at US$4.85 per share for aggregate gross proceeds of US$50 million, underwritten by Cantor and Barclays, with expected closing on June 25, 2026, subject to customary closing conditions and regulatory approvals.
View raw filing on EDGAR →Hertz announced a $100 million registered public offering of common stock to be loaned to J.P. Morgan Securities LLC for short-sale hedging by note investors, creating material economic dilution to existing shareholders through the short-sale mechanism.
View raw filing on EDGAR →uniQure entered into an underwriting agreement on June 23, 2026 for a registered public offering of 4,945,055 ordinary shares at $45.50 per share, with underwriters granted a 30-day option to purchase an additional 741,758 shares (exercised in full on June 24, 2026), expected to generate approximately $225 million in gross proceeds and materially dilute existing shareholders.
View raw filing on EDGAR →Definium entered into an underwriting agreement on June 23, 2026 for a public offering of 20,588,236 common shares at $34.00 per share, with underwriters exercising their full option for an additional 3,088,235 shares, generating approximately $805 million in gross proceeds. This registered public offering will dilute existing shareholders materially.
View raw filing on EDGAR →The filing discloses an ongoing private placement offering of up to $2.165 billion of common shares across multiple classes, with $534.084 million already raised as of May 31, 2026. This represents a substantial unregistered equity issuance that would dilute existing shareholders. While the filing also mentions dividend declarations and DRIP activity, the primary material event disclosed in Item 8.01 is the status and scale of the continuous private offering, which is a classic dilutive issuance event material to investors.
View raw filing on EDGAR →Absci entered into an underwriting agreement on June 24, 2026 to issue 13,495,277 shares of common stock at $7.41 per share, generating approximately $100 million in gross proceeds ($93.5 million net) pursuant to an effective Form S-3 shelf registration statement. The offering includes participation from strategic investors including Eli Lilly & Company and materially dilutes existing shareholders.
View raw filing on EDGAR →The Fund disclosed an unregistered sale of LLC units (equity securities) for $66.97 million pursuant to a capital call notice delivered to investors on June 22, 2026. The issuance is exempt under Section 4(a)(2) and Regulation D, which are hallmarks of private placements. This is a material capital raise that increases the Fund's equity base and dilutes existing unit holders' ownership percentages.
View raw filing on EDGAR →Fortress Private Lending Fund completed an unregistered sale of 182,155 Class I common shares for $4.4 million to accredited investors under Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →CalciMedica entered into a securities purchase agreement for a private placement of approximately $49 million in gross proceeds, comprising 18,673,429 units of common stock (or pre-funded warrants), Series A warrants, and Series B warrants. The unregistered securities rely on Section 4(a)(2) exemption and carry restrictive legends, with potential for up to $34 million additional proceeds if warrants are exercised.
View raw filing on EDGAR →The company issued 225,000 Class A Ordinary Shares to the Sponsor at $10.00 per share for $2.25 million in gross proceeds pursuant to Section 4(a)(2) of the Securities Act of 1933, a private placement concurrent with the IPO.
View raw filing on EDGAR →Wilco 63 Corporation issued 5,000,000 warrants to the Sponsor and Representative (Cantor) in an unregistered private placement at $1.00 per warrant ($5,000,000 aggregate), exercisable at $11.50 per share, pursuant to Section 4(a)(2) exemption.
View raw filing on EDGAR →The filing discloses a private placement of a convertible promissory note ($880,000 principal, $800,000 purchase price) and 10,000 commitment shares to FirstFire Global Opportunities Fund under Section 4(a)(2) and Regulation D exemptions. The convertible note is convertible into common stock at $5.00 per share, subject to an exchange cap of 10,686,477 shares pending stockholder approval. This is a classic dilutive equity issuance raising capital through a convertible debt instrument with significant equity upside, material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →GD Culture Group entered into a securities purchase agreement on June 24, 2026 to issue approximately 259.3 million shares of common stock at $0.021 per share in a registered direct offering, raising approximately $5.45 million in gross proceeds. This represents substantial dilution to existing shareholders.
View raw filing on EDGAR →The Company completed an unregistered private placement of 6,100,000 warrants to the Sponsor and Cohen & Company Capital Markets for $6.1 million aggregate consideration ($1.00 per warrant) simultaneously with the IPO closing.
View raw filing on EDGAR →On June 21, 2026, the Company entered into a Securities Purchase Agreement to issue approximately 12.2 million shares of common stock and pre-funded warrants in a private placement for approximately $19.5 million in aggregate consideration, with the proceeds used to retire existing debt. The securities were issued under Section 4(a)(2) and Regulation D exemptions to an accredited investor, substantially diluting existing shareholders and materially altering the capital structure.
View raw filing on EDGAR →The filing discloses a private placement of 20,000,000 shares of common stock at $0.60 per share, generating approximately $12,000,000 in gross proceeds. The shares were issued under Section 4(a)(2) of the Securities Act and Regulation S to non-U.S. accredited investors. This is a classic unregistered equity issuance (dilutive_issuance), disclosed under Items 1.01 and 3.02, representing a material capital raise for a small-cap company trading on Nasdaq Capital Market.
View raw filing on EDGAR →Worksport entered into two registered direct offerings on June 17–18, 2026, issuing 208,333 shares at $1.20 per unit (with warrants) and 675,529 shares at $0.70 per share, totaling approximately $722,870 in gross proceeds. The offerings include dilutive equity issuances and warrant grants with cashless exercise features, characteristic of a registered direct offering (PIPE-like structure). This is a material capital raise that dilutes existing shareholders and is disclosed under Item 1.01 (Entry into a Material Definitive Agreement).
View raw filing on EDGAR →Autozi announced execution of a Securities Purchase Agreement under which it issued convertible promissory notes totaling $5.25 million in gross proceeds, with an additional $2.5 million option. The notes are convertible into Ordinary Shares at a conversion price based on closing sale price at time of conversion. This is a dilutive equity issuance offered under Section 4(a)(2) and Regulation D exemptions, materially affecting shareholder equity and ownership structure.
View raw filing on EDGAR →HPS Corporate Capital Solutions Fund completed an unregistered private placement of approximately $16.91 million in common shares of beneficial interest across Class I and Class D shares, issued to accredited investors and non-U.S. persons pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D/S.
View raw filing on EDGAR →The filing discloses an unregistered sale of equity securities totaling approximately $243.9 million across three share classes (Class I, S, and D) on June 1, 2026, exempt under Section 4(a)(2) and Regulations D and S. This is a classic dilutive private placement. The materiality is underscored by the substantial aggregate consideration and the disclosure that the company has raised approximately $7.3 billion cumulatively since inception through such continuous private offerings.
View raw filing on EDGAR →The Company completed an unregistered sale of approximately $281 million in equity securities across multiple share classes (Class I, U, D, and S shares) to investors on June 1, 2026, exempt under Section 4(a)(2) and Regulations D and S. This private placement is part of the Company's ongoing continuous offering structure and materially affects shareholder ownership dilution.
View raw filing on EDGAR →The filing discloses an unregistered sale of 961,171 common shares for $25,125,000 pursuant to Section 4(a)(2) and Regulation D/S under the Securities Act. This is a classic dilutive equity issuance by a closed-end fund raising capital through a private placement, which is material to existing shareholders as it increases share count and dilutes ownership.
View raw filing on EDGAR →TPG Private Equity Opportunities, L.P. sold $99.2 million of unregistered limited partnership units on June 1, 2026, across multiple unit classes (Class I, S, and F) to third-party investors and through a feeder vehicle, pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →Carlyle Private Equity Partners Fund sold approximately $16.4 million in unregistered limited partnership units on June 1, 2026, pursuant to a continuous private offering under Section 4(a)(2) and Regulation D, diluting existing unitholders' ownership interests.
View raw filing on EDGAR →The filing discloses settlement of forward sale agreements under an ATM equity distribution program and underwritten forward sale agreements, resulting in the delivery of approximately 8.7 million shares of common stock and generating ~$672 million in gross proceeds. These forward sale agreements represent dilutive equity issuances that were previously entered into and are now being physically settled. The magnitude of shares issued and cash raised, combined with the disclosure of substantial remaining outstanding forward obligations (~11.1 million shares worth ~$915 million), constitutes a material capital-raising event affecting shareholder equity and ownership dilution.
View raw filing on EDGAR →AMC entered into a securities purchase agreement on June 23, 2026 to sell 95,250,000 shares of Class A common stock at $2.10 per share in a registered direct offering, raising approximately $200 million in gross proceeds for debt redemption and general corporate purposes. This material registered equity issuance will dilute existing shareholders' voting power and ownership percentage.
View raw filing on EDGAR →The company issued 21,953,577 shares of Reorganized Common Equity and New Warrants (exercisable for 5.0% of outstanding equity) without registration under the Securities Act in reliance on Section 1145(a) of the Bankruptcy Code to debt holders and other claimants in connection with the bankruptcy emergence.
View raw filing on EDGAR →Eagle Point Trinity Senior Secured Lending Co issued 36,782.83 common shares for $373,000 in aggregate proceeds pursuant to subscription agreements, with the offer and sale exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S.
View raw filing on EDGAR →Westport completed a registered direct offering of 1.6 million common shares and 3.25 million pre-funded warrants, combined with a concurrent private placement of 4.85 million warrants, raising approximately US$10 million in gross proceeds with potential for an additional US$10 million upon warrant exercise. The offering involved both registered and unregistered securities (private placement warrants under Section 4(a)(2) and Regulation D), materially diluting existing shareholders.
View raw filing on EDGAR →The press release announces a 1-for-25 reverse stock split effective June 26, 2026, reducing outstanding shares from ~15.1 million to ~605,000. While a reverse split itself is not a new issuance, it is a capital structure event that signals potential delisting risk mitigation—the Company explicitly states the purpose is "to maintain compliance with Nasdaq's continued listing requirements," suggesting the stock price had fallen below minimum thresholds. This is material to investors as it reflects compliance pressure and dilution concerns, though the classification is somewhat ambiguous between `dilutive_issuance` (capital structure change affecting share value) and `delisting_risk` (the underlying compliance issue). The reverse split is the disclosed action, making `dilutive_issuance` the best fit, though confidence is moderate given the reverse split itself does not create new shares.
View raw filing on EDGAR →The Company entered into a Securities Purchase Agreement on June 23, 2026, to issue a convertible promissory note ($1.5M principal at initial closing, up to $2M total) and warrants to purchase 468,978 Class A ordinary shares. The convertible note and warrant structure creates significant dilution to existing shareholders through conversion and exercise rights. This is a classic PIPE-like transaction raising capital through unregistered securities with conversion/exercise features, fitting the dilutive_issuance taxonomy.
View raw filing on EDGAR →Serapha Bio is raising $230 million through a private placement of capital stock in connection with the proposed merger, with approximately $138 million already funded in a Series A financing and $92 million expected to close concurrently with the merger closing.
View raw filing on EDGAR →Stepstone Private Credit Fund LLC completed an unregistered sale of 10,650,045 LLC interests for $279.6 million pursuant to subscription agreements, relying on Section 4(a)(2), Regulation D, and Regulation S exemptions. This private placement materially affects the registrant's capitalization and ownership structure.
View raw filing on EDGAR →Vista Credit Strategic Lending Corp. completed an unregistered sale of 147,178.274 shares of Class I and Class S common stock for $2,808,500 pursuant to subscription agreements, relying on Section 4(a)(2) and Regulations D and S exemptions.
View raw filing on EDGAR →North Haven Private Income Fund LLC completed an unregistered sale of approximately 338,864 Class S units for $6.12 million, relying on Section 4(a)(2) and Regulation D exemptions with accredited investor representations.
View raw filing on EDGAR →North Haven Private Income Fund A LLC completed an unregistered private placement of approximately 24,412 Class I units for $0.5 million at $19.81 per unit, pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →LGAM Private Credit LLC sold approximately 263,964 Common Units for $5.2 million at $19.61 per unit pursuant to subscription agreements, relying on Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →Zoomcar entered into a securities purchase agreement for a private placement of Series A Convertible Preferred Stock, Warrants, and Placement Agent Warrants under Section 4(a)(2) and Regulation D Rule 506(c), with the Second Closing involving issuance of 662 Units for approximately $537,000 in gross proceeds. The Preferred Shares are convertible into Common Stock at $0.05 per share and Warrants are exercisable at $0.0625 per share, materially diluting existing shareholders' ownership.
View raw filing on EDGAR →Aditxt conducted an unregistered sale of equity securities (Additional Notes) to accredited investors under Section 4(a)(2) and Regulation D Rule 506(b), representing a material private placement exempt offering.
View raw filing on EDGAR →E-Power Inc. entered into a subscription agreement on June 16, 2026, to issue 15,841,585 Class A ordinary shares at $1.01 per share for an aggregate purchase price of $16,000,000.85 to a non-U.S. purchaser under Regulation S. This is a private placement of equity securities that will dilute existing shareholders and raise capital, fitting the definition of dilutive_issuance.
View raw filing on EDGAR →The Company completed an unregistered private placement of a convertible note that would result in issuance of 20,000 private placement units upon conversion, together with warrants exercisable for Class A ordinary shares, relying on Section 4(a)(2) exemption for sophisticated investors.
View raw filing on EDGAR →The 6-K discloses a registered direct offering of 6,441,012 Class A ordinary shares at US$0.45645 per share for aggregate gross proceeds of approximately US$2.94 million. This is a direct equity issuance to investors pursuant to a Securities Purchase Agreement dated June 19, 2026, and is expected to close on or about June 25, 2026. The offering is registered under Form F-3 and represents a material capital-raising event that would dilute existing shareholders.
View raw filing on EDGAR →The filing discloses conversion of Series B Convertible Preferred Stock into common stock following stockholder approval at a June 12, 2026 special meeting. The conversion resulted in 53,539,119 shares of common stock outstanding as of June 17, 2026, and required Nasdaq Listing Rule 5635(d) approval because the issuance exceeded 19.99% of previously outstanding shares. This is a material dilutive issuance of equity securities that materially increases share count and would affect investor assessment of ownership dilution and voting power.
View raw filing on EDGAR →This exhibit is a Securities Purchase Agreement for an unregistered private placement of up to $30,000,000 of Ordinary Shares at USD 0.6 per share to non-US persons under Regulation S and Section 4(a)(2) exemptions. The agreement explicitly states the Company is relying on exemptions from securities registration and the Purchasers are "non-US persons" acquiring securities in a private placement. This is a material dilutive issuance of equity securities outside a registered offering, typical of PIPE or private placement activity that would materially affect shareholder equity and voting power.
View raw filing on EDGAR →Dreamland Limited entered into a securities purchase agreement on June 22, 2026, to issue 320,000 Class A ordinary shares at US$3.75 per share for aggregate gross proceeds of US$1,200,000. The shares were issued in an unregistered offshore transaction under Regulation S to a non-U.S. person (Imperial Vision Fund SPC Series 1 SP), with transfer restrictions and restrictive legends. This is a classic private placement of unregistered equity securities, which is material to investors as it represents dilution and a capital raise.
View raw filing on EDGAR →The filing discloses an unregistered private placement of 201,500 restricted shares of common stock to five private investors at $2.75 per share, completed in March and April 2026 and closed on June 23, 2026. Items 1.01 and 3.02 explicitly describe the issuance and claim exemptions under Section 4(a)(2) and Regulation D, which are hallmarks of a dilutive equity issuance. This represents a material capital-raising event that would affect shareholder ownership and the total mix of information available to investors.
View raw filing on EDGAR →The filing discloses entry into securities purchase agreements under Item 1.01 for the issuance of up to 43.3 billion units (each consisting of one share of common stock and one warrant) at $0.015 per unit for approximately $650 million in gross proceeds. An initial closing on June 22, 2026 resulted in issuance of 1.8 billion shares of common stock (900 million shares plus 900 million from warrant exercise). This is a classic dilutive private placement of equity securities to non-U.S. investors, materially diluting existing shareholders and raising substantial capital.
View raw filing on EDGAR →Sharplink entered into a securities purchase agreement on June 22, 2026, to sell 10,013,351 shares of common stock at $7.49 per share (approximately $75 million gross proceeds) plus 10,013,351 warrants with an exercise price of $8.15 per share. This is a registered direct offering disclosed under Item 1.01 (Entry into a Material Definitive Agreement), representing a dilutive equity issuance to raise capital for cryptocurrency acquisition and general corporate purposes. The transaction is material to investors as it significantly increases share count and dilution.
View raw filing on EDGAR →The filing discloses an unregistered sale of 356 Series A Convertible Preferred Shares to TriCore Foundation, LLC for $320,400 on June 17, 2026, made in reliance on Section 4(a)(2) of the Securities Act. This is a classic dilutive issuance under Item 3.02, involving convertible securities sold to a related party without registration. The transaction is material as it represents new equity capital raised and potential dilution to existing shareholders upon conversion.
View raw filing on EDGAR →